
Release date: 2026-01-26 17:46:01 Article From: Lucius Laos Recommended: 233
Concurrent use of this medicine with any of the following medications is generally not recommended, but may be necessary in certain circumstances. If both medications are prescribed together, your doctor may adjust the dosage or frequency of administration of one or both drugs.
Relevant drugs include abametapir, acalabrutinib, live adenovirus type 4 vaccine, live adenovirus type 7 vaccine, alfentanil, amiodarone, amlodipine, aprepitant, atogepant, atrasentan, avacopan, avanafil, avapritinib, bedaquiline, benzhydrocodone, betrixaban, boceprevir, bosentan, bosutinib, brigatinib, budesonide, buprenorphine, bupropion, buspirone, cabozantinib, capmatinib, cariprazine, cenobamate, cholera vaccine, clarithromycin, cobicistat, cobimetinib, codeine, conivaptan, crizanlizumab, cyclosporine, dabigatran etexilate, dalidazole, darifenacin, etc. In addition, there are many other drugs for which attention should be paid to concurrent use; specific management and adjustments should be carried out in accordance with the doctor's advice.
Certain medications should not be used during meals or before/after consuming specific types of food, as interactions may occur. Concurrent use of alcohol or tobacco with certain medications may also lead to interactions. Please discuss with your healthcare professional the use of this medicine together with food, alcohol, or tobacco.
The presence of other medical conditions may affect the use of this medicine. Be sure to inform your doctor if you have any other health problems, especially the following:
1. A history of depression.
2. Diabetes mellitus.
3. Cardiac rhythm disorders.
4. Hyperglycemia (high blood sugar levels).
5. Hyperlipidemia (high fat levels in the blood).
6. Hypertension (high blood pressure).
7. Pulmonary or respiratory disorders.
8. A history of seizures — use with caution. This may exacerbate these conditions.
9. Severe renal impairment.
10. Moderate or severe hepatic impairment — use with caution. The effects of the drug may be enhanced due to reduced elimination from the body.
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended:[list:visits]2025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended:[list:visits]2024-09-07
Alectinib Has Been Launched in LaosAlectinib is an oral targeted therapeutic drug belonging to the c···【more】
Recommended:[list:visits]2026-30-07
Lucius Pharmaceuticals Quizartinib (Quizartinib) Has Been Launched(1) Quizartinib is an oral tablet.···【more】
Recommended:[list:visits]2026-29-07
Lucius Pharmaceutical is a modern pharmaceutical enterprise headquartered in Vientiane, the capital ···【more】
Recommended:[list:visits]2026-28-07
Lucius Pharmaceuticals Relocates from India to Laos: A Five-Year Development Journey of a Generic Dr···【more】
Recommended:[list:visits]2026-24-07
In recent years, Laos has gradually become a major global supply source for generic drugs, leveragin···【more】
Recommended:[list:visits]2026-22-07
Lucius version of Dacomitinib is now availableCutaneous adverse reactions and management strategies ···【more】
Recommended:[list:visits]2026-21-07

Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address: No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com

Name: Lucius

Telegram name: Vira
No.:0085253923643
Telegram name: Vira
No.:0085253923643